Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ObsEva SA - Common Shares (NQ:OBSV)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Mar 22, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ObsEva SA - Common Shares

< Previous 1 2 3 4 5 6 Next >
News headline image
18 Stocks Moving in Monday's Pre-Market Session ↗
Gainers FGI Industries Ltd. (NASDAQ: FGI) rose 92.8% to $7.27 in pre-market trading after jumping 19% on Friday. The company, last week, priced its IPO at $6 per... 
Via Benzinga
News headline image
7 Penny Stocks to Buy for January ↗
These penny stocks look poised for a rally in January 2022 and can possibly deliver multi-fold returns in the next 12 months. 
Via InvestorPlace
News headline image
33 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Eargo, Inc. (NASDAQ: EAR) shares jumped 50.8% to $6.88 after the company announced the Department of Justice confirmed to it that the previously-announced criminal probe... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Illumina Announces Co-Development Partnership With SomaScan For Accelerating... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
Good morning, trader! Let's start off the day right with a look into some of the biggest pre-market stock movers for Thursday! 
Via InvestorPlace
News headline image
23 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) rose 54.3% to $0.9490 in pre-market trading after declining more than 11% on Wednesday. Alterity Therapeutics Limited... 
Via Benzinga
News headline image
7 of the Best Penny Stocks Under $3 for 2022 to Buy Now ↗
Penny stocks under $3 are full of potential and potential pitfalls. These are relatively safe and worth your consideration. 
Via InvestorPlace
News headline image
Why Are ObsEva Shares Trading Higher Today? ↗
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending approval for ObsEva SA'... 
Via Benzinga
News headline image
28 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Genfit SA (NASDAQ: GNFT) shares jumped 33.6% to $4.41 after the company, and Ipsen, announced an exclusive licensing agreement for elafibranor. X4 Pharmaceuticals, Inc... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗
Good morning, investor! We're in the home stretch of the week as we tackle the biggest pre-market stock movers for Friday! 
Via InvestorPlace
News headline image
20 Stocks Moving in Friday's Pre-Market Session ↗
Gainers Genfit SA (NASDAQ: GNFT) rose 47.5% to $4.90 in pre-market trading. Ipsen and GENFIT reported an exclusive licensing agreement for Elafibranor. Spruce Biosciences, Inc. (... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly Sings Metabolic Disorder Drug Pact, Moderna Reports Positive Flu Vaccine Data, Halozyme To Buy Back Shares ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Angion Biomedica's ANG-3777 Does Not Meet Primary Endpoint In Mid-Stage... 
Via Benzinga
News headline image
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More ↗
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative... 
Via Benzinga
News headline image
10 Biggest Price Target Changes For Monday ↗
Citigroup cut Merck & Co., Inc. (NYSE: MRK) price target from $105 to $85. Merck shares fell 2% to $77.55 in pre-market trading. Keybanc lowered Arista Networks, Inc. (... 
Via Benzinga
News headline image
7 Hot Penny Stocks to Buy for December That Are Positioned to Pop ↗
These penny stocks remain positioned to run upwards in the near term. Purchasing shares in December could quickly lead to profits. 
Via InvestorPlace
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗
Welcome back, traders! We're getting right into the week with a breakdown of the biggest pre-market stock movers for Monday! 
Via InvestorPlace
News headline image
20 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Astra Space, Inc. (NASDAQ: ASTR) rose 39.6% to $13.30 in pre-market trading after declining around 3% on Friday. Astra Space recently reported a Q3 loss of $0.06 per... 
Via Benzinga
News headline image
ObsEva Shares Jump After Linzagolix Application For Uterine Fibroids Goes Under FDA Review ↗
The FDA has accepted for review ObsEva SA's (NASDAQ: OBSV) marketing application for linzagolix to manage heavy menstrual bleeding associated with uterine... 
Via Benzinga
News headline image
7 Penny Stocks to Book Profits on Before 2022 ↗
Penny stocks can turn a quick profit. These 7 picks are designed to do so before the end of this year and cover multiple sectors. 
Via InvestorPlace
News headline image
24 Stocks Moving in Thursday's Pre-Market Session ↗
Gainers Evaxion Biotech A/S (NASDAQ: EVAX) rose 143.5% to $15.83 in pre-market trading after dropping over 10% on Wednesday. TDH Holdings, Inc. (NASDAQ: PETZ) rose 72.6% to $4.09... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19... 
Via Benzinga
News headline image
ObsEva Presents Linzagolix Data From Uterine Fibroid Trials ↗
ObsEva SA (NASDAQ: OBSV) has announced data from PRIMROSE (1 and 2) Phase 3 study of linzagolix for uterine fibroids. The data were presented at the American... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar Line Treatment Review On Track Responding to the... 
Via Benzinga
News headline image
26 Stocks Moving in Wednesday's Pre-Market Session ↗
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) rose 46.1% to $0.6699 in pre-market trading after dropping 11% on Tuesday. MeaTech 3D Ltd. (NASDAQ: MITC) rose 18.5% to $6.29 in pre-market... 
Via Benzinga
News headline image
ObsEva Files US Application For Linzagolix For Uterine Fibroids ↗
ObsEva SA (NASDAQ: OBSV) has submitted a marketing application to the FDA seeking approval for linzagolix for uterine fibroids. Linzagolix is an oral GnRH receptor... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)... 
Via Benzinga
News headline image
44 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement with the National Research Council of Canada that... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
News headline image
62 Biggest Movers From Yesterday ↗
Gainers Intrusion Inc. (NASDAQ: INTZ) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced... 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.